Endotoxin Alters Early Fetal Lung Morphogenesis

Journal of Surgical Research

Volumn 155, Issue 2, 2009, Pages 225-230

  Muratore, Christopher S ^a   Luks, Francois I ^a   Zhou, Yonghong ^a   Harty, Mark ^a   Reichner, Jonathan ^a   Tracy, Thomas F ^a  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

endotoxin; inflammation; lung development

Indexed keywords

CD31 ANTIGEN; CYCLOOXYGENASE 2; ENDOTOXIN; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; HEMATOXYLIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; PARAFFIN; PROSTAGLANDIN; VASCULOTROPIN;

AIR SAC; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; COMPUTER PROGRAM; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FETUS; FETUS CELL; FETUS LUNG; GENE EXPRESSION; GESTATION PERIOD; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG DEVELOPMENT; LUNG STRUCTURE; MESENCHYME; MITOGENESIS; MORPHOGENESIS; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD31; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 9; LIPOPOLYSACCHARIDES; LUNG; MODELS, ANIMAL; MORPHOGENESIS; NITRIC OXIDE SYNTHASE TYPE II; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67651115865     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.06.043     Document Type: Article

References (11)

1. Goldenberg R.L., Hauth J.C., and Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 342 (2000) 1500
2. Jobe A.H., and Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2 (2001) 27
3. Lebeche D., Malpel S., and Cardoso W.V. Fibroblast growth factor interactions in the developing lung. Mech Dev 86 (1999) 125
4. Colvin J.S., White A.C., Pratt S.J., et al. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128 (2001) 2095
5. Jobe A.H. Antenatal associations with lung maturation and infection. J Perinatol 25 Suppl 2 (2005) S31
6. Jobe A.H. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 8 (2003) 9
7. Kallapur S.G., and Jobe A.H. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed 91 (2006) F132
8. Benjamin J.T., Smith R.J., Halloran B.A., et al. FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation. Am J Physiol Lung Cell Mol Physiol 292 (2007) L550
9. Cardoso W.V., and Lu J. Regulation of early lung morphogenesis: Questions, facts, and controversies. Development 133 (2006) 1611
10. Moss T.J., Newnham J.P., Willett K.E., et al. Early gestational intra-amniotic endotoxin: Lung function, surfactant, and morphometry. Am J Respir Crit Care Med 165 (2002) 805
11. Rae C., Cherry J.I., Land F.M., et al. Endotoxin-induced nitric oxide production rescues airway growth and maturation in atrophic fetal rat lung explants. Biochem Biophys Res Commun 349 (2006) 416